Home / Inspections / 1239090

FDA Inspection 1239090 — Cadila Pharmaceuticals Limited

Cadila Pharmaceuticals Limited — FEI 3002806711

The FDA completed an inspection of Cadila Pharmaceuticals Limited on May 10, 2024 in Ankleshwar. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
May 10, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Ankleshwar (India)

Facility

Other inspections at this facility

  • 1102381 (VAI Fri Aug 09 2019 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 1044877 (VAI Tue Feb 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 982066 (OAI Mon Jul 25 2016 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 873262 (OAI Fri Mar 28 2014 00:00:00 GMT+0000 (Coordinated Universal Time))
  • 664596 (VAI Fri Dec 11 2009 00:00:00 GMT+0000 (Coordinated Universal Time))

Recent compliance actions

FDA data resources